ITMCTR2100004625RecruitingPhase 1
Based on the association study of intestinal microecology and TCM tongue diagnosis study on the establishment of a precise diagnosis and treatment system for membranous nephropathy in traditional Chinese medicine
onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Idiopathic membranous nephropathy group:
- •(1) It meets the diagnostic criteria of Western medicine and is confirmed to be an IMN patient by renal biopsy and clinical examination;
- •(2) 24-hour urine protein quantitative >= 1g, eGFR > 30ml/min/1.73m2;
- •(3) 18-75 years old, regardless of gender or ethnicity;
- •(4) The patient gave informed consent and signed the informed consent form.
- •2. CKD group of non-membranous nephropathy:
- •(1) Non-MN patients who meet the diagnostic criteria of Western medicine and are confirmed by renal biopsy;
- •(2) 24-hour urine protein quantitative >= 1g, eGFR > 30ml/min/1.73m2;
- •(3) 18-75 years old, regardless of gender or ethnicity;
- •(4) The patient gave informed consent and signed the informed consent form.
- •3. Healthy volunteer group:
- •(1) Healthy adults, between the ages of 18-75, regardless of gender or ethnicity;
- •(2) The patient gave informed consent and signed the informed consent form.
Exclusion Criteria
- •(1) Rapidly progressing CKD;
- •(2) Merge other pathological types of MN;
- •(3) Have received immunosuppressant or cytotoxic drug treatment for more than 4 weeks in the past 6 months;
- •(4) Have received glucocorticoids (prednisone or prednisone) at a dose of more than 20 mg/d for more than 4 weeks in the past 6 months;
- •(5) Those with life-threatening complications such as severe infections;
- •(6) Those with positive HBV serological indicators other than HbsAb and those with abnormal transaminase in continuous liver function tests;
- •(7) Patients with malignant tumors or patients with malignant tumor history, history of HIV infection, history of mental illness, acute central nervous system disease, severe gastrointestinal disease, and patients who are prohibited from using immunosuppressive agents;
- •(8) Poor blood sugar control, fasting blood sugar >= 7.0mmol/L;
- •(9) Pregnant or lactating women;
- •(10) Undergoing other clinical trials and research;
- •(11) Combined with serious diseases and dysfunction of other organs;
- •(12) Taking probiotics for treatment in the past month;
- •(13) Take antibiotic treatment in the past 3 months;
- •(14) Hypertension has poor blood pressure control, blood pressure >= 140/90mmHg;
- •(15) Those who are deemed unsuitable to participate in this research after the comprehensive evaluation of the research.
Investigators
Similar Trials
Recruiting
Not Applicable
Study on the correlation between intestinal microbiota and portal vein thrombosis and cirrhosisPortal vein thrombosis, Liver cirrhosisJPRN-UMIN000043536Kanazawa University40
Recruiting
Phase 1
Study on the characteristics of intestinal microecological community and its correlation with syndromes in patients with early age-related macular degeneration (AMD)ITMCTR2100004463Eye Hospital, China Academy of Chinese Medical Sciences
Recruiting
Not Applicable
Study on the relationship between gastrointestinal microflora and gastrointestinal metabolic diseasesMetabolic Diseases Related to Gastrointestinal DiseasesJPRN-UMIN000044910Kyushu University400
Completed
Phase 1
Study on intestinal microecological disorder of lung and gastrointestinal heat syndrome in children with respiratory tract infectioRespiratory tract infection in childrenITMCTR2200005509Beijing University of Chinese Medicine
Unknown
Not Applicable
Study of interactions between intestinal microflora, intestinal macrofauna and antibiotic use in adults living in Lambaréné, GaboDigestive SystemGut Flora and faunaPACTR201707002361207Centre de Recherches Médicales de Lambaréné (CERMEL), Albert Schweitzer Hospital Lambaréné, Gabon40